UK's NICE says Alzheimer’s drugs aren't worth national coverage
Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla should not be covered under the UK's national health insurance because the Alzheimer's drugs' benefits don't outweigh their high cost, the country's drug coverage advisor said. ...
Biogen and Eisai’s Leqembi and Eli Lilly’s Kisunla should not be covered under the UK's national health insurance because the Alzheimer's drugs' benefits don't outweigh their high cost, the country's drug coverage advisor said. ...
